An Open-Label, Parallel-Group, Phase 1 Study to Evaluate the Pharmacokinetics, Safety, and Tolerability of BG00012 in Chinese, Japanese, and Caucasian Adult Healthy Volunteers

Trial Profile

An Open-Label, Parallel-Group, Phase 1 Study to Evaluate the Pharmacokinetics, Safety, and Tolerability of BG00012 in Chinese, Japanese, and Caucasian Adult Healthy Volunteers

Completed
Phase of Trial: Phase I

Latest Information Update: 06 Jun 2015

At a glance

  • Drugs Dimethyl fumarate (Primary)
  • Indications Multiple sclerosis; Psoriasis; Rheumatoid arthritis
  • Focus Pharmacokinetics
  • Sponsors Biogen
  • Most Recent Events

    • 07 Jun 2012 Actual patient number is 71 according to ClinicalTrials.gov.
    • 07 Jun 2012 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
    • 22 Mar 2012 Additional location (Australia) added as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top